Observational studyCurrent oncology (Toronto, Ont.)2026
Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study.
Beyza Ünlü et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.